뉴스벤징가
Better Cancer Therapy Than Keytruda? Summit Therapeutics Partner's Ivonescimab Outperforms in Lung Cancer Study
· 발표
기사 요약
Summit Therapeutics' partner Akeso reported positive overall survival results for ivonescimab in a Phase 3 lung cancer clinical trial.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…